Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
5.52
-0.21 (-3.66%)
At close: Nov 26, 2025, 4:00 PM EST
5.58
+0.06 (1.09%)
After-hours: Nov 26, 2025, 7:57 PM EST
Korro Bio Revenue
Korro Bio had revenue of $1.09M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $7.37M. In the year 2024, Korro Bio had annual revenue of $2.27M.
Revenue (ttm)
$7.37M
Revenue Growth
n/a
P/S Ratio
7.03
Revenue / Employee
$70,875
Employees
104
Market Cap
51.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.27M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionKRRO News
- 13 days ago - Korro Bio Early Trial Results Fall Short; Stock Hits New Low - Benzinga
- 14 days ago - This biotech is halting its work with Novo Nordisk and laying off more people - Market Watch
- 14 days ago - Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs - GlobeNewsWire
- 3 months ago - Korro to Participate in Upcoming Investor and Scientific Conferences - GlobeNewsWire
- 3 months ago - Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 - GlobeNewsWire
- 7 months ago - Korro to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Korro Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire